RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Reperfusion Injury |
|
Accession: | DOID:9004009
|
browse the term
|
Definition: | Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the tissue (REPERFUSION), including swelling; HEMORRHAGE; NECROSIS; and damage from FREE RADICALS. The most common instance is MYOCARDIAL REPERFUSION INJURY. |
Synonyms: | exact_synonym: | Ischemia Reperfusion Injury; Ischemia-Reperfusion Injuries; Reperfusion Damage; Reperfusion Damages; Reperfusion Injuries |
| primary_id: | MESH:D015427 |
| xref: | EFO:0002687 |
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22749977 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
|
IEP |
mRNA, protein:increased expression:brain, neuron |
RGD |
PMID:16997484 |
RGD:2301088 |
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
|
IEP |
mRNA, protein:increased expression, altered localization:small intestine |
RGD |
PMID:18451542 |
RGD:2315580 |
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IMP |
|
RGD |
PMID:20436217 |
RGD:2325213 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
IEP |
mRNA:increased expression:hippocampal granule cell |
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
|
|
G |
Adcyap1r1 |
ADCYAP receptor type I |
|
IEP |
mRNA:decreased expression:dentate gyrus (rat) |
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chr 4:84,593,558...84,642,700
Ensembl chr 4:84,593,892...84,642,700
|
|
G |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
|
IEP |
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chr19:24,202,405...24,244,137
Ensembl chr19:24,204,360...24,244,139
|
|
G |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
|
IEP |
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chr14:26,336,320...27,104,060
Ensembl chr14:26,368,277...27,105,860
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
IMP |
associated with Non-alcoholic Fatty Liver Disease; |
RGD |
PMID:18098300 |
RGD:5686804 |
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adm |
adrenomedullin |
|
IEP |
protein:increased expression:plasma: |
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora2a |
adenosine A2a receptor |
|
IDA ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:27757725 PMID:17937935 |
RGD:4890367 |
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Adora2b |
adenosine A2B receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27757725 |
|
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
IMP |
|
RGD |
PMID:20451506 |
RGD:5129116 |
NCBI chr 1:255,772,217...255,773,617
Ensembl chr 1:255,771,597...255,807,259
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
IDA |
|
RGD |
PMID:14630341 PMID:18336819 |
RGD:1598754, RGD:4145097 |
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
IDA |
|
RGD |
PMID:22920387 |
RGD:6903870 |
NCBI chr X:112,119,673...112,124,060
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
IEP |
protein:increased expression:Kupffer cell (rat) |
RGD |
PMID:16500929 |
RGD:2313040 |
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
|
RGD |
PMID:21351045 |
RGD:5509067 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16397181 |
|
NCBI chr 1:95,333,186...95,339,678
Ensembl chr 1:95,332,898...95,339,677
|
|
G |
Alb |
albumin |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:20193666 |
RGD:2325686 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
|
IEP |
|
RGD |
PMID:10395295 |
RGD:1599061 |
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
|
IEP |
|
RGD |
PMID:15518705 |
RGD:5509617 |
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:18635843 |
RGD:5509608 |
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
IEP ISO IMP |
protein:increased expression:cerebral hemisphere CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15266012 PMID:14769366 PMID:19816089 |
RGD:1626152, RGD:2317531 |
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Ang |
angiogenin |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:19666176 |
RGD:2325717 |
NCBI chr15:24,317,733...24,323,361
|
|
G |
Angpt1 |
angiopoietin 1 |
|
ISO |
|
RGD |
PMID:19885826 |
RGD:2316041 |
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
|
IMP |
|
RGD |
PMID:16339390 |
RGD:2313821 |
NCBI chr10:86,272,757...86,280,702
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
IEP |
|
RGD |
PMID:18205898 |
RGD:2292105 |
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
IEP |
protein:increased expression:placenta |
RGD |
PMID:18373555 |
RGD:2315671 |
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Aqp4 |
aquaporin 4 |
|
IEP ISO |
protein:increased expression:cerebral cortex mRNA, protein:increased expression:parietal cortex |
RGD |
PMID:20979759 PMID:21718723 PMID:19806476 PMID:20924629 |
RGD:5148016, RGD:5684013, RGD:5148037, RGD:5148022 |
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Arg1 |
arginase 1 |
|
IEP |
protein:increased expression:serum (rat) |
RGD |
PMID:17023552 |
RGD:4143185 |
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Asl |
argininosuccinate lyase |
resistance |
IEP |
protein:increased expression:brain, neuron (rat) |
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
resistance |
IEP |
protein:increased expression:brain, neuron (rat) |
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Bad |
BCL2-associated agonist of cell death |
|
IEP |
protein:altered localization:brain, mitochondria |
RGD |
PMID:18347331 |
RGD:2292679 |
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bag1 |
BAG cochaperone 1 |
|
IMP |
|
RGD |
PMID:12215270 |
RGD:2296021 |
NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075
|
|
G |
Bag3 |
BAG cochaperone 3 |
|
IEP |
protein:increased expression:hippocampus, astrocyte |
RGD |
PMID:12061864 |
RGD:2325848 |
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:18083315 PMID:18221257 |
RGD:2290557, RGD:2293026 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15449323 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
IEP |
mRNA:increased expression:retina |
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:22306244 |
RGD:6483054 |
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
IDA |
|
RGD |
PMID:19888517 |
RGD:2317562 |
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
IEP IMP |
protein:increased expression:brain |
RGD |
PMID:18159002 PMID:18053646 |
RGD:2293126, RGD:2293127 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
|
IEP |
|
RGD |
PMID:11245809 |
RGD:2289024 |
NCBI chr17:26,318,121...26,469,034
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
|
IEP |
mRNA:increased expression:dentate gyrus, granule cell |
RGD |
PMID:10996456 |
RGD:5129486 |
NCBI chr 9:61,192,718...61,307,280
Ensembl chr 9:61,190,566...61,301,809
|
|
G |
Bsg |
basigin (Ok blood group) |
|
IEP |
protein:increased expression:basal ganglia |
RGD |
PMID:16029217 |
RGD:2289063 |
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
IEP |
mRNA:increased expression:kidney |
RGD |
PMID:9712737 |
RGD:2289078 |
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
C3 |
complement C3 |
|
IEP |
protein:increased expression:intestine |
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C3ar1 |
complement C3a receptor 1 |
|
IMP |
|
RGD |
PMID:15159277 |
RGD:5129702 |
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
|
|
G |
C5 |
complement C5 |
|
IDA |
|
RGD |
PMID:15158333 |
RGD:1600597 |
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
C5ar1 |
complement C5a receptor 1 |
|
IMP |
|
RGD |
PMID:15158333 PMID:15159277 |
RGD:1600597, RGD:5129702 |
NCBI chr 1:76,948,622...76,959,826
|
|
G |
Casp1 |
caspase 1 |
|
IMP |
|
RGD |
PMID:17845807 |
RGD:2315890 |
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
|
IEP |
|
RGD |
PMID:18273070 |
RGD:2311461 |
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
treatment |
IMP IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23875703 PMID:18490106 PMID:29568770 |
RGD:2293311, RGD:13792595 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
|
IEP |
protein:increased expression, increased activity:small intestine mucosa |
RGD |
PMID:15010362 |
RGD:2301320 |
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
treatment |
IDA |
|
RGD |
PMID:29568770 |
RGD:13792595 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cast |
calpastatin |
|
IEP |
|
RGD |
PMID:11035539 |
RGD:5509823 |
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Cat |
catalase |
|
IDA ISO IEP |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:8215636 PMID:16682413 PMID:23743330 PMID:23875703 PMID:19196076 PMID:20888583 More...
|
RGD:5130760, RGD:5130200 |
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:17293479 |
RGD:2289123 |
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
|
IEP |
mRNA:increased expression:aorta |
RGD |
PMID:9665468 |
RGD:4145482 |
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
IDA ISO |
Gastric Reperfusion Injury CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12468449 PMID:15829914 PMID:22611311 |
RGD:8549744 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15829914 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO IEP |
protein:increased secretion:lung, secretion (mouse) protein:increased expression:gut |
RGD |
PMID:19558673 PMID:15542513 |
RGD:4891479, RGD:2307184 |
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccnb1 |
cyclin B1 |
|
IEP |
protein;altered expression:cerebral cortex, hippocampus CA1, neuron |
RGD |
PMID:18278459 |
RGD:2315990 |
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
|
IEP |
|
RGD |
PMID:16718823 |
RGD:2289145 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:17584601 |
RGD:2289275 |
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccng1 |
cyclin G1 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:9698156 |
RGD:2316027 |
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:20410256 |
RGD:5688141 |
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Cd2ap |
CD2-associated protein |
|
IEP |
|
RGD |
PMID:16088078 |
RGD:1581187 |
NCBI chr 9:18,086,744...18,182,744
Ensembl chr 9:18,086,984...18,182,199
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd40 |
CD40 molecule |
|
IMP |
|
RGD |
PMID:12388354 |
RGD:5508171 |
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO IMP |
|
RGD |
PMID:20659085 PMID:12388354 |
RGD:5490531, RGD:5508171 |
NCBI chr X:135,127,119...135,138,302
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
|
IEP |
protein:increased expression:kidney protein:increased expression:testis, macrophage |
RGD |
PMID:16786159 PMID:16891795 |
RGD:2289354, RGD:2289369 |
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
|
IEP |
|
RGD |
PMID:20403613 |
RGD:2326175 |
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Cd59b |
CD59b molecule |
|
IDA |
|
RGD |
PMID:10530491 |
RGD:1600493 |
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cdc42 |
cell division cycle 42 |
|
IDA |
protein:increased activation:hippocampus CA1 |
RGD |
PMID:17161586 |
RGD:2298583 |
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16968891 PMID:10451498 |
RGD:10043817 |
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
IEP |
protein:increased expression:skeletal muscle |
RGD |
PMID:15799773 |
RGD:2293627 |
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cfh |
complement factor H |
|
IEP |
protein:increased expression:plasma: |
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Chat |
choline O-acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Cldn4 |
claudin 4 |
|
IEP |
protein:increased expression, altered localization:small intestine epithelium |
RGD |
PMID:17375208 |
RGD:2317600 |
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
IMP |
|
RGD |
PMID:19372445 |
RGD:2314674 |
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
IEP |
|
RGD |
PMID:17565360 |
RGD:5686869 |
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Ctsb |
cathepsin B |
|
IEP |
protein:increased expression:cerebral cortex, mitochondrion (rat) |
RGD |
PMID:18938146 |
RGD:2315506 |
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsg |
cathepsin G |
|
ISO |
|
RGD |
PMID:17322378 |
RGD:7242055 |
NCBI chr15:29,930,988...29,937,353
Ensembl chr15:29,931,003...29,937,353
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:19563789 |
RGD:4891956 |
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO IEP |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16526316 PMID:20160675 PMID:10655268 |
RGD:5134970, RGD:5135270 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
IEP ISO |
mRNA:increased expression:liver protein:increased expression:respiratory system fluid/secretion associated with Anemia, Sickle Cell;protein:increased expression:lung |
RGD |
PMID:18589091 PMID:16709871 PMID:19433855 |
RGD:2311376, RGD:5135441, RGD:5135307 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
IEP |
protein:increased expression:retina |
RGD |
PMID:18709383 |
RGD:2306570 |
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP ISO |
mRNA:increased expression:jejunum, lung CTD Direct Evidence: marker/mechanism protein:increased expression:liver mRNA:increased expression:liver |
CTD RGD |
PMID:12468449 PMID:19691980 PMID:10655268 PMID:11580116 PMID:20160675 |
RGD:5134974, RGD:5135270, RGD:5135251, RGD:5134970 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:11580116 PMID:10655268 |
RGD:5135251, RGD:5135270 |
NCBI chr14:17,310,089...17,312,303
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
associated with Anemia, Sickle Cell;protein:increased expression:lung |
RGD |
PMID:19433855 |
RGD:5135307 |
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:18589091 |
RGD:2311376 |
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
|
IEP |
|
RGD |
PMID:15148062 |
RGD:1599683 |
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
|
IEP ISO |
Protein:increase expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19193722 PMID:16766636 |
RGD:1599677 |
NCBI chr X:13,360,583...13,392,517
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
IEP |
protein:increased expression:hippocampus (rat) |
RGD |
PMID:21114983 |
RGD:4890041 |
NCBI chr 8:54,553,165...54,580,758
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:21094789 |
RGD:4892235 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22749977 |
|
NCBI chr12:16,397,998...16,433,833
Ensembl chr12:16,397,998...16,433,833
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22749977 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
IEP |
protein:increased expression:kidney |
RGD |
PMID:18790177 |
RGD:4781446 |
NCBI chr X:71,661,415...71,690,158
Ensembl chr X:71,663,821...71,690,121
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:21664436 |
RGD:5144004 |
NCBI chr15:48,190,251...48,229,906
Ensembl chr15:48,189,073...48,304,136
|
|
G |
Dcc |
DCC netrin 1 receptor |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:17574219 |
RGD:2314372 |
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
|
|
G |
Dsg1 |
desmoglein 1 |
|
IEP |
protein:decreased expression:lung |
RGD |
PMID:19500802 |
RGD:2316254 |
NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
|
|
G |
Edn1 |
endothelin 1 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17470888 PMID:18722366 |
RGD:4892577 |
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Edn2 |
endothelin 2 |
|
IEP |
|
RGD |
PMID:1479622 |
RGD:1580920 |
NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:133,751,217...133,756,814
|
|
G |
Ednrb |
endothelin receptor type B |
|
IEP |
|
RGD |
PMID:18722366 |
RGD:4892577 |
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
IEP |
protein:hypophosphorylation:cortex, hippocampus: |
RGD |
PMID:15211596 |
RGD:10401223 |
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Efna5 |
ephrin A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 9:102,316,753...102,595,480
Ensembl chr 9:102,320,295...102,597,413
|
|
G |
Efnb2 |
ephrin B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Egf |
epidermal growth factor |
resistance |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16526316 PMID:16417467 |
RGD:6906916 |
NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egr1 |
early growth response 1 |
|
ISO IEP |
Lung Reperfusion Injury CTD Direct Evidence: marker/mechanism Lung Reperfusion Injury; protein:increased expression:lung, nucleus (rat) Lung Reperfusion Injury; protein:increased expression:lung, nucleus (mouse) |
CTD RGD |
PMID:12468449 PMID:16551742 PMID:16488723 PMID:19342415 |
RGD:5131903, RGD:5131904, RGD:5131887 |
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19041636 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
IDA |
protein:increased phosphorylation:kidney |
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
|
IDA |
protein:increased phosphorylation:kidney |
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eno2 |
enolase 2 |
|
IDA |
|
RGD |
PMID:17683050 |
RGD:2293745 |
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Ep300 |
E1A binding protein p300 |
treatment |
IDA IEP |
retina retina; protein:altered localization:Hsp70, promoter (rat) |
RGD |
PMID:22143029 PMID:22143029 |
RGD:5686888, RGD:5686888 |
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epha2 |
Eph receptor A2 |
|
IDA |
|
RGD |
PMID:16735461 |
RGD:1580976 |
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
|
RGD |
PMID:19471280 |
RGD:5688359 |
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
IMP |
|
RGD |
PMID:19440222 |
RGD:2313668 |
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
|
|
G |
F2 |
coagulation factor II |
|
IMP |
|
RGD |
PMID:20705928 |
RGD:5147777 |
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
IDA |
|
RGD |
PMID:29568770 |
RGD:13792595 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
|
IDA ISO |
Rat model using human FGF1 |
RGD |
PMID:19497570 PMID:16635575 |
RGD:5509879, RGD:5509881 |
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
IEP ISO |
protein:increased expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:7922267 PMID:15121240 |
RGD:2293779 |
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:15306117 |
RGD:1642465 |
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:15121240 |
RGD:2293779 |
NCBI chr 6:24,297,898...24,319,157
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
IEP |
|
RGD |
PMID:17250641 |
RGD:2307361 |
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gast |
gastrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10594344 |
|
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
|
|
G |
Gh1 |
growth hormone 1 |
treatment |
ISO |
|
RGD |
PMID:21439711 |
RGD:10003153 |
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16581065 |
|
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25530438 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
|
IEP |
protein:decreased activity:brain |
RGD |
PMID:7808037 |
RGD:6484655 |
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
|
IEP |
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
|
IEP |
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8215636 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23743330 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
|
IEP |
mRNA:decreased expression:hippocampus (rat) |
RGD |
PMID:20408958 |
RGD:4107069 |
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
|
IMP |
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
|
|
G |
Grik5 |
glutamate ionotropic receptor kainate type subunit 5 |
|
IMP |
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
|
IEP |
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chr10:5,630,684...6,043,341
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
|
IEP |
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:24904723 |
RGD:10401882 |
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
|
RGD |
PMID:17142801 |
RGD:6903953 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7635938 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
IDA |
Spinal Cord Reperfusion Injury Limb Reperfusion Injury |
RGD |
PMID:16465055 PMID:23816242 |
RGD:9068924, RGD:9068927 |
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
IMP |
|
RGD |
PMID:22392147 |
RGD:10402071 |
NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
IMP ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:21724106 PMID:16009498 PMID:18398369 |
RGD:5508445, RGD:5508473, RGD:2315888 |
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IDA ISO IEP IMP |
CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:serum, Bronchoalveolar Lavage Fluid |
CTD RGD |
PMID:12352873 PMID:16982915 PMID:17660127 PMID:17906103 PMID:23075401 PMID:25780291 PMID:16699460 PMID:19885035 PMID:12919086 More...
|
RGD:1582708, RGD:4145338, RGD:4145514 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hrh3 |
histamine receptor H3 |
|
IDA |
|
RGD |
PMID:17169356 |
RGD:1626416 |
NCBI chr 3:167,191,551...167,196,642
Ensembl chr 3:167,191,558...167,196,642
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
|
ISO IEP |
|
RGD |
PMID:10965299 PMID:10550516 |
RGD:7242748, RGD:7242749 |
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7922267 |
|
NCBI chr20:3,870,765...3,873,221
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
IMP |
associated with Diabetes Mellitus, experimental (D003921): protein:increased expression:brain |
RGD |
PMID:22075494 |
RGD:5685650 |
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10216529 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19193722 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11557319 PMID:23743330 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Ifng |
interferon gamma |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:19514843 |
RGD:2308950 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO |
|
RGD |
PMID:16306169 |
RGD:1598442 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il10 |
interleukin 10 |
|
IEP ISO IDA |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18460982 PMID:19514843 PMID:12388354 PMID:16141682 |
RGD:2308950, RGD:5508171, RGD:1598625 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il13 |
interleukin 13 |
|
IEP ISO |
protein:decreased expression:plasma |
RGD |
PMID:18354382 PMID:18354382 |
RGD:2301685, RGD:2301685 |
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:19394645 PMID:16052682 |
RGD:4889555, RGD:4889825 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10594344 PMID:12468449 PMID:15829914 PMID:19058328 PMID:19673871 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:lung |
CTD RGD |
PMID:15829914 PMID:17032661 PMID:18258783 PMID:19673871 PMID:21940958 PMID:20680426 PMID:20659747 More...
|
RGD:4143250, RGD:4143253 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
|
|
G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chr 9:88,287,680...88,392,748
Ensembl chr 9:88,287,677...88,392,746
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Itga2b |
integrin subunit alpha 2b |
|
IMP |
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chr10:87,408,532...87,426,055
Ensembl chr10:87,408,536...87,426,168
|
|
G |
Itga5 |
integrin subunit alpha 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
IMP |
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
|
RGD |
PMID:20440769 |
RGD:6483026 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7922267 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
IDA |
|
RGD |
PMID:10708603 |
RGD:1581697 |
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
|
|
G |
Kdr |
kinase insert domain receptor |
|
IEP ISO |
mRNA:increased expression:hippocampus CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16526316 PMID:17402857 |
RGD:5684415 |
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
ISO IEP |
protein:decreased expression:brain, neuron, cytoplasm (mouse) protein:decreased expression:left coronary artery (rat) |
RGD |
PMID:21075092 PMID:18078953 |
RGD:6893270, RGD:6902919 |
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Klk1 |
kallikrein 1 |
|
IEP |
|
RGD |
PMID:12746231 |
RGD:1641806 |
NCBI chr 1:94,642,722...94,646,714
Ensembl chr 1:94,642,687...94,646,754
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
IEP |
|
RGD |
PMID:17288738 |
RGD:2324630 |
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lep |
leptin |
|
IDA |
|
RGD |
PMID:21086559 |
RGD:5128549 |
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lig3 |
DNA ligase 3 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr10:67,717,796...67,741,141
Ensembl chr10:67,717,812...67,798,414
|
|
G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:19773801 |
RGD:2325809 |
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
|
|
G |
Map2 |
microtubule-associated protein 2 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:21948028 |
RGD:6483082 |
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20302854 PMID:16699462 |
RGD:1582310 |
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
IDA |
protein:increased activity:hippocampus |
RGD |
PMID:16805806 |
RGD:2293339 |
NCBI chr10:13,918,417...13,958,335
Ensembl chr10:13,918,400...13,958,273
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19667931 PMID:20302854 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mb |
myoglobin |
|
ISO |
|
RGD |
PMID:12788661 |
RGD:1582427 |
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
|
|
G |
Mbl1 |
mannose binding lectin 1 |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:16982912 PMID:15509537 |
RGD:1582132, RGD:6903263 |
NCBI chr16:17,029,146...17,035,187
Ensembl chr16:17,029,118...17,035,174
|
|
G |
Mbl2 |
mannose binding lectin 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15882434 PMID:15509537 |
RGD:6903262, RGD:6903263 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mc1r |
melanocortin 1 receptor |
no_association |
ISO |
|
RGD |
PMID:18757499 |
RGD:5687323 |
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
|
|
G |
Mdk |
midkine |
|
ISO |
|
RGD |
PMID:15780085 |
RGD:1582475 |
NCBI chr 3:77,901,156...77,903,997
Ensembl chr 3:77,901,158...77,903,130
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
IEP |
mRNA:increased expression:retina (rat) |
RGD |
PMID:17113948 |
RGD:2317505 |
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mif |
macrophage migration inhibitory factor |
disease_progression |
ISO |
|
RGD |
PMID:18055556 |
RGD:4891010 |
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Mir148b |
microRNA 148b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30308185 |
|
NCBI chr 7:134,421,398...134,421,494
Ensembl chr 7:134,421,398...134,421,494
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
IEP |
protein:increased protein, activity:brain |
RGD |
PMID:15099024 |
RGD:2325962 |
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO IMP |
CTD Direct Evidence: marker/mechanism associated with lung injury; mRNA, protein:increased expression:lung protein:increased expression:limb muscle (mouse) |
CTD RGD |
PMID:23075401 PMID:16551680 PMID:19545667 PMID:16251419 |
RGD:1582618, RGD:5129531, RGD:1582631 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
|
IEP ISO |
protein:increased activity:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:8869312 PMID:10706834 PMID:12024109 PMID:16971220 PMID:19058328 PMID:20863214 PMID:21470877 More...
|
RGD:5130958 |
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mt-atp6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
|
IEP |
|
RGD |
PMID:20450733 |
RGD:5490294 |
NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
|
|
G |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
|
IEP |
|
RGD |
PMID:20450733 |
RGD:5490294 |
NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
|
IEP |
mRNA:decreased expression:kidney |
RGD |
PMID:7692737 |
RGD:2298967 |
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mt2A |
metallothionein 2A |
|
ISO |
mRNA:increased expression:cerebrum (mouse) |
RGD |
PMID:12122050 |
RGD:6483850 |
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
|
RGD |
PMID:19635467 |
RGD:6480529 |
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
IEP |
|
RGD |
PMID:23977093 |
RGD:7349380 |
NCBI chr 2:174,635,559...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Nes |
nestin |
|
IEP |
protein:increased expression:cerebral cortex |
RGD |
PMID:17569338 |
RGD:1642074 |
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
IEP |
protein:increased expression:small intestine |
RGD |
PMID:20107953 |
RGD:5131440 |
NCBI chr19:18,379,720...18,422,817
Ensembl chr19:18,382,439...18,417,177
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
IMP |
|
RGD |
PMID:17451676 |
RGD:1642142 |
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
IEP ISO |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism protein:increased expression:venule, arteriole, endothelium (mouse) mRNA, protein:increased expression:liver |
CTD RGD |
PMID:10383581 PMID:19673871 PMID:23061969 PMID:23075401 PMID:11592783 PMID:22019501 PMID:14599979 More...
|
RGD:2325259, RGD:5509100, RGD:1580938 |
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21968084 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nox4 |
NADPH oxidase 4 |
|
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:18438942 |
RGD:2324666 |
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Oga |
O-GlcNAcase |
|
IMP |
|
RGD |
PMID:16899550 |
RGD:2305957 |
NCBI chr 1:244,598,285...244,633,835
Ensembl chr 1:244,598,292...244,634,359
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
|
IEP |
mRNA, protein:decreased expression:hippocampus |
RGD |
PMID:17360495 |
RGD:2316611 |
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
|
|
G |
Otc |
ornithine transcarbamylase |
|
IEP |
protein:increased activity:serum |
RGD |
PMID:1499453 |
RGD:4144083 |
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
|
|
G |
Oxt |
oxytocin/neurophysin I prepropeptide |
|
IMP |
|
RGD |
PMID:18403049 |
RGD:2304111 |
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (rat) |
CTD RGD |
PMID:15696051 PMID:16798486 PMID:9390645 PMID:21850691 |
RGD:5510018, RGD:5510020 |
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
IEP ISO |
|
RGD |
PMID:19142196 PMID:19142196 |
RGD:6483555, RGD:6483555 |
NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
|
|
G |
Pde5a |
phosphodiesterase 5A |
|
IMP |
|
RGD |
PMID:19474186 |
RGD:2314462 |
NCBI chr 2:210,858,515...211,003,480
Ensembl chr 2:210,858,063...210,999,701
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
IMP IEP ISO |
protein:decreased expression:lung (rat) protein:increased expression:brain (mouse) |
RGD |
PMID:12121711 PMID:21872880 PMID:22382321 |
RGD:2311660, RGD:6771206, RGD:6766379 |
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
IEP |
proetin:decreased dimerization:skeletal muscle (rat) |
RGD |
PMID:19100383 |
RGD:4108481 |
NCBI chr 2:32,878,942...32,963,611
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pink1 |
PTEN induced kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35312153 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pklr |
pyruvate kinase L/R |
|
IEP |
|
RGD |
PMID:17013507 |
RGD:1625588 |
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12967936 |
|
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
|
IDA |
protein:increased activity:alveolar macrophage |
RGD |
PMID:1642455 |
RGD:1642456 |
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Plat |
plasminogen activator, tissue type |
|
IDA ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:9472885 PMID:15223382 |
RGD:2311674 |
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plau |
plasminogen activator, urokinase |
|
IEP ISO |
protein:increased expression:spinal cord (rat) CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:15181847 PMID:19663807 PMID:18586014 |
RGD:6483808, RGD:6483830 |
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
|
ISO |
|
RGD |
PMID:18606671 |
RGD:6483829 |
NCBI chr 1:80,053,441...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Pld2 |
phospholipase D2 |
|
IEP |
protein:increased expression:hippocampus CA1, hippocampus granule cell layer mRNA:decreased expression:brainstem, cerebellum |
RGD |
PMID:17393174 PMID:17024567 |
RGD:2299901, RGD:2299902 |
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
|
|
G |
Pnmt |
phenylethanolamine-N-methyltransferase |
|
ISO |
protein:increased expression:medulla oblongata (human) |
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chr10:83,383,019...83,386,557
Ensembl chr10:83,384,923...83,386,556
|
|
G |
Polb |
DNA polymerase beta |
|
IEP |
protein:increased expression:cerebral cortex |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr16:69,379,438...69,402,710
Ensembl chr16:69,379,400...69,404,812
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
IDA ISO |
liver ischemia/reperfusion injury CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:19151258 PMID:21305343 |
RGD:5509942 |
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12468449 PMID:24011919 PMID:24433871 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
|
IDA |
|
RGD |
PMID:14762344 |
RGD:1580702 |
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
|
|
G |
Ppp3cb |
protein phosphatase 3 catalytic subunit beta |
|
ISO |
|
RGD |
PMID:14615291 |
RGD:1580705 |
NCBI chr15:3,759,950...3,804,976
Ensembl chr15:3,760,030...3,804,981
|
|
G |
Prdx6 |
peroxiredoxin 6 |
|
ISO |
|
RGD |
PMID:16766642 |
RGD:1580710 |
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
|
|
G |
Prkca |
protein kinase C, alpha |
|
IMP |
|
RGD |
PMID:17905752 |
RGD:2292474 |
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prss1 |
serine protease 1 |
|
IEP |
|
RGD |
PMID:11062314 |
RGD:1599961 |
NCBI chr 4:70,364,589...70,367,792
Ensembl chr 4:70,364,586...70,367,792
|
|
G |
Ptafr |
platelet-activating factor receptor |
treatment |
ISO IMP |
|
RGD |
PMID:12812996 PMID:11139461 |
RGD:1581279, RGD:10043168 |
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
|
|
G |
Pten |
phosphatase and tensin homolog |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19038262 PMID:17239858 |
RGD:2292538 |
NCBI chr 1:230,631,303...230,696,754
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptges |
prostaglandin E synthase |
|
IEP ISO |
|
RGD |
PMID:12431630 PMID:16864802 |
RGD:2300116, RGD:2300094 |
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10594344 PMID:16385084 |
RGD:5688223 |
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IEP ISO IMP IDA |
protein:decreased expression:kidney CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10588920 PMID:10594344 PMID:11567657 PMID:16386242 PMID:18258783 PMID:19673871 PMID:21394482 PMID:21944479 PMID:16247333 More...
|
RGD:5135045, RGD:5508180, RGD:1580660 |
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
|
IEP |
protein:increased tyrosine phosphorylation:kidney |
RGD |
PMID:17620366 |
RGD:2292577 |
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
IDA |
protein:increased phosphorylation:hippocampus |
RGD |
PMID:15970382 |
RGD:1642621 |
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
IEP ISO |
protein:increased expression:nucleus, liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20302854 PMID:23743330 PMID:18621400 |
RGD:2298777 |
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
S100b |
S100 calcium binding protein B |
|
IEP |
|
RGD |
PMID:18840784 |
RGD:5508834 |
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
ISO |
|
RGD |
PMID:16403835 |
RGD:1580913 |
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
|
|
G |
Scfd1 |
sec1 family domain containing 1 |
|
IEP |
protein:increased expression:cerebral cortex |
RGD |
PMID:9195952 |
RGD:633771 |
NCBI chr 6:68,795,810...68,874,076
Ensembl chr 6:68,795,878...68,874,078
|
|
G |
Sele |
selectin E |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17112405 PMID:23743330 PMID:19489247 |
RGD:2313598 |
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Sell |
selectin L |
|
IEP |
|
RGD |
PMID:19489247 |
RGD:2313598 |
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Selp |
selectin P |
|
IEP ISO |
|
RGD |
PMID:18521901 PMID:21701413 |
RGD:2312314, RGD:6218990 |
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
|
|
G |
Serpine2 |
serpin family E member 2 |
|
IEP |
|
RGD |
PMID:8261109 |
RGD:2317936 |
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:23991040 |
RGD:8661644 |
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
|
|
G |
Sftpc |
surfactant protein C |
|
IDA |
mRNA:decreased expression:lung |
RGD |
PMID:20560845 |
RGD:4144062 |
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
G |
Si |
sucrase-isomaltase |
|
IEP |
|
RGD |
PMID:9724271 |
RGD:1625550 |
NCBI chr 2:157,505,893...157,586,228
Ensembl chr 2:157,506,342...157,585,260
|
|
G |
Sirt7 |
sirtuin 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28675767 |
|
NCBI chr10:105,896,476...105,903,301
Ensembl chr10:105,896,476...105,903,172
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:19781384 |
RGD:2313601 |
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:19781384 |
RGD:2313601 |
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
|
|
G |
Slc30a4 |
solute carrier family 30 member 4 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:18289514 |
RGD:2299950 |
NCBI chr 3:109,753,270...109,775,306
Ensembl chr 3:109,753,273...109,775,306
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
IEP |
protein:decreased expression:renal proximal tubule |
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chr17:9,218,876...9,233,852
Ensembl chr17:9,218,876...9,233,852
|
|
G |
Slc6a11 |
solute carrier family 6 member 11 |
|
IEP |
|
RGD |
PMID:13678673 |
RGD:1299345 |
NCBI chr 4:147,297,972...147,413,319
Ensembl chr 4:147,297,969...147,413,443
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
|
IEP |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
|
|
G |
Slc8a2 |
solute carrier family 8 member A2 |
|
IEP |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr 1:76,816,583...76,852,928
Ensembl chr 1:76,808,725...76,847,072
|
|
G |
Slc8a3 |
solute carrier family 8 member A3 |
|
IEP |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr 6:100,874,359...101,007,989
Ensembl chr 6:100,874,369...101,007,508
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
|
IMP ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:19027022 PMID:20337040 |
RGD:6771332 |
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
|
IEP |
mRNA:decreased expression:liver |
RGD |
PMID:16858290 |
RGD:2303111 |
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
|
|
G |
Slk |
STE20-like kinase |
|
IEP |
protein:increased expression:kidney |
RGD |
PMID:12965890 |
RGD:2304069 |
NCBI chr 1:246,473,712...246,529,643
Ensembl chr 1:246,473,712...246,526,530
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8215636 |
|
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
IDA |
associated with Brain Ischemia;mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Socs4 |
suppressor of cytokine signaling 4 |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr15:20,523,406...20,537,889
Ensembl chr15:20,523,183...20,542,494
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:15364863 PMID:16397181 PMID:23061969 PMID:23743330 PMID:15364863 |
RGD:1580834 |
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
IEP ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:8215636 PMID:16682413 PMID:19193722 PMID:19917352 PMID:21940958 PMID:23743330 PMID:15612529 PMID:15087276 More...
|
RGD:1582141, RGD:1581259 |
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
|
ISO |
|
RGD |
PMID:15778274 |
RGD:1581264 |
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
|
RGD |
PMID:20548025 |
RGD:6903275 |
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
|
IEP |
protein:increased phosphorylation:hippocampus CA1 (rat) |
RGD |
PMID:20197063 |
RGD:2325012 |
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
IDA IEP |
protein:increased serine phosphorylation:brain protein:increased phosphorylation:kidney |
RGD |
PMID:15262323 PMID:17670769 |
RGD:1600103, RGD:2291900 |
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
|
|
G |
Stc1 |
stanniocalcin 1 |
|
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
|
|
G |
Stc2 |
stanniocalcin 2 |
|
IEP |
mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
|
IEP ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25922074 PMID:16908442 |
RGD:2302564 |
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
|
IDA |
associated with Cholestasis, Extrahepatic |
RGD |
PMID:15000260 PMID:8680115 |
RGD:1601451, RGD:1601475 |
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16968891 |
|
NCBI chr 1:29,637,213...29,659,509
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tfam |
transcription factor A, mitochondrial |
|
IDA |
|
RGD |
PMID:22266265 |
RGD:6767573 |
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
IEP |
|
RGD |
PMID:15613744 |
RGD:1579926 |
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Th |
tyrosine hydroxylase |
|
ISO |
protein:increased expression:medulla oblongata (human) |
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
|
RGD |
PMID:19342415 |
RGD:5131887 |
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
|
|
G |
Thbs1 |
thrombospondin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 3:105,056,286...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
|
|
G |
Ticam1 |
TIR domain containing adaptor molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291 |
|
NCBI chr 9:1,102,559...1,115,573
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
IEP |
protein:decreased expression:brain |
RGD |
PMID:17551674 |
RGD:2290424 |
NCBI chr 7:17,520,827...17,571,871
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tjp1 |
tight junction protein 1 |
|
IEP |
protein:decreased expression:brain, endothelial cell |
RGD |
PMID:19374856 PMID:19929946 |
RGD:2325135, RGD:2325127 |
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
IEP ISO |
mRNA, protein:increased expression:kidney CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25780291 PMID:15912106 |
RGD:2312727 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr3 |
toll-like receptor 3 |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:21355876 |
RGD:5128693 |
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
IEP ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25780291 PMID:27064547 PMID:19473433 PMID:17126102 |
RGD:2312503, RGD:4144169 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tmbim6 |
transmembrane BAX inhibitor motif containing 6 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:18005084 |
RGD:2291961 |
NCBI chr 7:130,512,428...130,543,637
Ensembl chr 7:130,527,316...130,543,633
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10706834 PMID:12024109 PMID:15829914 PMID:16971220 PMID:17112405 PMID:18460982 PMID:19058328 PMID:23743330 PMID:23875703 PMID:24898700 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
IEP |
|
RGD |
PMID:17109621 |
RGD:1624182 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tp53 |
tumor protein p53 |
|
IEP |
protein:increased expression:brain, mitochondrion |
RGD |
PMID:17661174 |
RGD:2290568 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
treatment |
IDA |
|
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
IEP |
mRNA,protein:increased expression:hippocampus |
RGD |
PMID:18395621 |
RGD:5684390 |
NCBI chr 3:114,046,258...114,134,799
Ensembl chr 3:114,046,258...114,135,190
|
|
G |
Txn1 |
thioredoxin 1 |
|
IEP |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txn2 |
thioredoxin 2 |
|
IEP |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
|
IEP |
mRNA:decreased expression:cerebral cortex mRNA:decreased expression:spinal cord |
RGD |
PMID:19128823 PMID:19409971 |
RGD:5685030, RGD:5685028 |
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
|
IEP |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
IEP |
mRNA:increased expression:kidney |
RGD |
PMID:18813897 |
RGD:2313108 |
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfc |
vascular endothelial growth factor C |
|
IEP |
|
RGD |
PMID:18704465 |
RGD:2315487 |
NCBI chr16:37,712,408...37,827,657
Ensembl chr16:37,712,262...37,827,848
|
|
G |
Vegfd |
vascular endothelial growth factor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:21693218 |
RGD:5685379 |
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
|
|
G |
Wnt3a |
Wnt family member 3A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23875703 |
|
NCBI chr10:44,034,174...44,078,463
Ensembl chr10:44,034,194...44,078,324
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12910483 PMID:23403765 |
RGD:7247700 |
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
G |
Zfp354a |
zinc finger protein 354A |
|
IEP |
mRNA:decreased expression:kidney |
RGD |
PMID:8382778 |
RGD:1300202 |
NCBI chr10:35,396,242...35,408,065
Ensembl chr10:35,396,231...35,408,068
|
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
IEP |
|
RGD |
PMID:9916935 |
RGD:11341701 |
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Hnrnpk |
heterogeneous nuclear ribonucleoprotein K |
|
ISO |
|
RGD |
PMID:21489814 |
RGD:155260371 |
NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
|
|
G |
Pdgfd |
platelet derived growth factor D |
|
ISO |
|
RGD |
PMID:19213942 |
RGD:9854642 |
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
|
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
treatment |
IEP |
|
RGD |
PMID:22217518 PMID:23769041 |
RGD:7245568, RGD:8695995 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
C3 |
complement C3 |
treatment |
IDA |
|
RGD |
PMID:25122638 |
RGD:11040803 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cd40 |
CD40 molecule |
treatment |
IDA |
|
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
IDA |
liver |
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chr X:135,127,119...135,138,302
Ensembl chr X:135,126,969...135,138,306
|
|
G |
F7 |
coagulation factor VII |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:12095034 |
RGD:11049508 |
NCBI chr16:76,489,779...76,500,636
Ensembl chr16:76,489,717...76,500,610
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
IEP |
|
RGD |
PMID:22217518 |
RGD:7245568 |
NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
IDA |
|
RGD |
PMID:23985719 |
RGD:10041002 |
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
IMP |
|
RGD |
PMID:24598936 |
RGD:10450586 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Aco1 |
aconitase 1 |
|
IEP |
|
RGD |
PMID:20176611 |
RGD:11541086 |
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:24370342 |
RGD:11035281 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
ISO |
|
RGD |
PMID:17298994 |
RGD:7241819 |
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccn2 |
cellular communication network factor 2 |
disease_progression |
IEP |
mRNA, protein:increased expression:kidney (rat) |
RGD |
PMID:19921985 |
RGD:150517553 |
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Clu |
clusterin |
treatment |
IEP |
|
RGD |
PMID:22494435 |
RGD:9068431 |
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cs |
citrate synthase |
treatment |
IDA |
|
RGD |
PMID:20005400 |
RGD:243048470 |
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
ISO |
|
RGD |
PMID:22845765 |
RGD:7241226 |
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
treatment |
IDA |
|
RGD |
PMID:18209025 |
RGD:9685339 |
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
|
IEP |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
IEP |
mRNA:increased expression:kidney: |
RGD |
PMID:15785371 PMID:11889420 |
RGD:10449491, RGD:11080974 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
IEP |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
IEP |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr18:54,500,002...54,538,843
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
protein:increased secretion:T lymphocyte (human) |
RGD |
PMID:16387096 |
RGD:7241259 |
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712 |
RGD:13208600 |
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712 PMID:18192922 |
RGD:13208600, RGD:13208601 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:22305384 |
RGD:10395369 |
NCBI chr 6:7,790,236...7,871,246
Ensembl chr 6:7,790,647...7,871,228
|
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
|
IEP |
mRNA,protein:decreased expression:stomach: |
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Kitlg |
KIT ligand |
|
IEP |
mRNA:decreased expression:stomach: |
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IEP |
|
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Agt |
angiotensinogen |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
IEP |
|
RGD |
PMID:24232000 |
RGD:13792678 |
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:23946597 |
RGD:13782356 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
treatment |
IEP |
|
RGD |
PMID:23946597 |
RGD:13782356 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:small intestine |
RGD |
PMID:18475188 |
RGD:2307016 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cd14 |
CD14 molecule |
|
IEP |
protein:increased expression:heart, kidney, liver, lung |
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cldn1 |
claudin 1 |
|
IEP |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn3 |
claudin 3 |
|
IEP |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Cldn5 |
claudin 5 |
|
IEP |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
|
|
G |
Crp |
C-reactive protein |
|
IEP |
protein:increased expression:intestine: |
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
|
RGD |
PMID:9117128 |
RGD:11039476 |
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
F7 |
coagulation factor VII |
|
ISO |
human protein in a rat model |
RGD |
PMID:22920553 |
RGD:11041662 |
NCBI chr16:76,489,779...76,500,636
Ensembl chr16:76,489,717...76,500,610
|
|
G |
Faslg |
Fas ligand |
treatment |
IEP |
|
RGD |
PMID:29170412 |
RGD:13792603 |
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
IEP |
|
RGD |
PMID:22093738 |
RGD:10402181 |
NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IEP |
|
RGD |
PMID:19362701 |
RGD:10766423 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hp |
haptoglobin |
treatment |
IEP |
|
RGD |
PMID:11922743 |
RGD:11041790 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
IEP |
|
RGD |
PMID:12095141 |
RGD:11522715 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il6 |
interleukin 6 |
treatment |
IDA |
|
RGD |
PMID:11959089 |
RGD:11062110 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jak2 |
Janus kinase 2 |
|
IMP |
|
RGD |
PMID:22777122 |
RGD:10403072 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
IEP |
protein:increased expression:heart, kidney, liver, lung |
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Mbl2 |
mannose binding lectin 2 |
severity |
ISO |
DNA:polymorphisms:exon: |
RGD |
PMID:19477015 |
RGD:12910933 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
miRNA:increased expression:Peyer's patch |
RGD |
PMID:30206757 |
RGD:21409753 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir21 |
microRNA 21 |
|
IEP |
|
RGD |
PMID:30309483 |
RGD:41410822 |
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IDA |
|
RGD |
PMID:16610051 |
RGD:7777112 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IEP |
|
RGD |
PMID:28382390 |
RGD:13440093 |
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
disease_progression |
IEP |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:23331901 |
RGD:15042883 |
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Parg |
poly (ADP-ribose) glycohydrolase |
treatment |
IMP |
|
RGD |
PMID:15791006 |
RGD:13514040 |
NCBI chr16:7,436,429...7,544,276
Ensembl chr16:7,436,476...7,544,273
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
ISO |
mRNA:increased expression:jejunum (human) |
RGD |
PMID:20965186 |
RGD:9999150 |
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:15187522 |
RGD:11250409 |
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
|
|
G |
Serpinc1 |
serpin family C member 1 |
treatment |
IEP |
|
RGD |
PMID:21046505 |
RGD:11035258 |
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Serpine1 |
serpin family E member 1 |
|
IDA |
protein:increased activity:plasma (rat) |
RGD |
PMID:12717359 |
RGD:11081012 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
treatment |
IEP |
|
RGD |
PMID:27538408 |
RGD:151347179 |
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
|
IEP |
|
RGD |
PMID:27538408 |
RGD:151347179 |
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
ameliorates |
IDA |
associated with mesenteric vascular occlusion; |
RGD |
PMID:18091551 |
RGD:127284848 |
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
|
|
G |
Vwf |
von Willebrand factor |
|
IEP |
protein:increased expression:plasma: |
RGD |
PMID:10365842 |
RGD:11080742 |
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:23010742 |
RGD:13209016 |
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IMP |
|
RGD |
PMID:21680852 |
RGD:6893484 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
|
IEP |
mRNA:decreased expression:kidney |
RGD |
PMID:20528771 |
RGD:9685432 |
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Acvr2b |
activin A receptor type 2B |
treatment |
ISO |
human construct in rat model |
RGD |
PMID:27732750 |
RGD:329322881 |
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
treatment |
IEP |
|
RGD |
PMID:22015440 |
RGD:13703100 |
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Adam2 |
ADAM metallopeptidase domain 2 |
|
IEP |
|
RGD |
PMID:11967014 |
RGD:10047130 |
NCBI chr15:40,242,783...40,284,025
Ensembl chr15:40,242,783...40,283,952
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
IEP |
|
RGD |
PMID:18272597 |
RGD:9684850 |
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
ISO |
|
RGD |
PMID:21412771 |
RGD:8695946 |
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adm |
adrenomedullin |
treatment |
IEP ISO |
protein:increased expression:serum: |
RGD |
PMID:20538296 PMID:20538296 |
RGD:7364948, RGD:7364948 |
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
|
RGD |
PMID:31089212 |
RGD:27226686 |
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
|
RGD |
PMID:22022451 |
RGD:7241603 |
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Anxa1 |
annexin A1 |
treatment |
IDA |
|
RGD |
PMID:20953576 |
RGD:7421585 |
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
|
RGD |
PMID:21918686 |
RGD:7242028 |
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
treatment |
IEP |
|
RGD |
PMID:26362957 |
RGD:13703110 |
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apoa1 |
apolipoprotein A1 |
treatment |
ISO |
|
RGD |
PMID:18535924 |
RGD:7241574 |
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Atm |
ATM serine/threonine kinase |
|
IEP |
protein:increased expression:kidney |
RGD |
PMID:22768306 |
RGD:10053607 |
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:18221257 PMID:29285062 |
RGD:2293026, RGD:13792599 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:18725957 |
RGD:7241559 |
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
|
|
G |
Becn1 |
beclin 1 |
treatment |
IEP |
|
RGD |
PMID:26412257 |
RGD:11561958 |
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
IEP |
mRNA, protein:increased expression:kidney |
RGD |
PMID:23698117 |
RGD:11561968 |
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
C3 |
complement C3 |
treatment |
IEP |
|
RGD |
PMID:19691975 |
RGD:7411689 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
|
IMP |
|
RGD |
PMID:19194162 |
RGD:7204479 |
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
|
IEP |
|
RGD |
PMID:17596683 |
RGD:5684536 |
NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
treatment |
ISO |
|
RGD |
PMID:22160777 |
RGD:7247742 |
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
ISO IDA |
mRNA, protein:increased expression:kidney, lung, serum |
RGD |
PMID:20396927 PMID:18650485 |
RGD:4891433, RGD:11526113 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:10966493 |
RGD:7204444 |
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd40 |
CD40 molecule |
treatment |
IMP |
|
RGD |
PMID:25993320 |
RGD:11251055 |
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cfb |
complement factor B |
|
ISO |
|
RGD |
PMID:16467447 PMID:12538716 |
RGD:7242709, RGD:7242734 |
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cfh |
complement factor H |
treatment |
IEP ISO |
protein:decreased expression:serum: |
RGD |
PMID:20538296 PMID:20538296 |
RGD:7364948, RGD:7364948 |
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Ciita |
class II, major histocompatibility complex, transactivator |
|
ISO |
|
RGD |
PMID:14569092 |
RGD:7242896 |
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
|
|
G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr X:67,350,376...67,355,072
Ensembl chr X:67,350,373...67,355,162
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:23143303 PMID:19196448 |
RGD:7257565, RGD:7257570 |
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
|
RGD |
PMID:23143303 |
RGD:7257565 |
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
ISO |
|
RGD |
PMID:22189844 PMID:9407517 |
RGD:7204675, RGD:7204727 |
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:20038794 |
RGD:7257679 |
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
IEP |
protein:increased expression:kidney |
RGD |
PMID:29073721 |
RGD:13825150 |
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
treatment |
IMP |
|
RGD |
PMID:23552495 |
RGD:7244372 |
NCBI chr 8:54,553,165...54,580,758
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Daxx |
death-domain associated protein |
|
ISO |
protein:increased expression:kidney: |
RGD |
PMID:18480747 PMID:18480747 |
RGD:9587836, RGD:9587836 |
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
ISO |
protein:increased expression:kidney (mouse) |
RGD |
PMID:31383731 |
RGD:151347540 |
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Dhfr |
dihydrofolate reductase |
|
IEP |
mRNA,protein:decreased expression:kidney: |
RGD |
PMID:18408363 |
RGD:11040540 |
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
Drd3 |
dopamine receptor D3 |
treatment |
IDA |
|
RGD |
PMID:25989500 |
RGD:13506961 |
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
|
|
G |
Eed |
embryonic ectoderm development |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 1:143,867,875...143,895,008
Ensembl chr 1:143,867,875...143,894,974
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
|
IEP |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chr19:52,867,914...52,907,169
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
|
IEP |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Elane |
elastase, neutrophil expressed |
treatment |
IMP |
|
RGD |
PMID:16980042 |
RGD:10450580 |
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
|
|
G |
Eng |
endoglin |
|
IEP ISO |
mRNA, protein:increased expression:kidney (rat) |
RGD |
PMID:16751653 PMID:16751653 |
RGD:7248779, RGD:7248779 |
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Ep300 |
E1A binding protein p300 |
|
IEP |
protein:altered localization:kidney (rat) |
RGD |
PMID:23936185 |
RGD:7257563 |
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:19961832 PMID:25581532 |
RGD:10401077, RGD:11041698 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
IEP |
protein:decreased expression:lung |
RGD |
PMID:25883098 |
RGD:11341735 |
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
IEP |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
treatment |
IEP |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fcgr1a |
Fc gamma receptor 1A |
treatment |
ISO |
|
RGD |
PMID:22402584 |
RGD:9685699 |
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
|
|
G |
Fga |
fibrinogen alpha chain |
|
IEP |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chr 2:168,365,364...168,381,533
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgb |
fibrinogen beta chain |
treatment |
IEP ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:21685370 PMID:21685370 |
RGD:7175292, RGD:7175292 |
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
exacerbates ameliorates |
ISO IMP |
protein:increased phosphorylation:kidney (mouse) |
RGD |
PMID:20591940 PMID:22688984 PMID:29344510 PMID:32523960 |
RGD:155663667, RGD:155882537, RGD:155782904, RGD:155782882 |
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgg |
fibrinogen gamma chain |
|
IEP |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fn1 |
fibronectin 1 |
|
IEP |
|
RGD |
PMID:11352844 |
RGD:7205629 |
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:19095962 |
RGD:7242184 |
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
IEP ISO |
protein:increased expression:kidney: |
RGD |
PMID:20332418 PMID:20332418 |
RGD:9685723, RGD:9685723 |
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
|
|
G |
Glo1 |
glyoxalase 1 |
|
IMP |
|
RGD |
PMID:19211689 |
RGD:7242566 |
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP |
|
RGD |
PMID:24630969 |
RGD:10401866 |
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
IEP |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:29137244 |
RGD:158014894 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
H2ax |
H2A.X variant histone |
treatment |
IEP |
|
RGD |
PMID:23726287 |
RGD:8693706 |
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Has1 |
hyaluronan synthase 1 |
|
IEP |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 1:58,693,411...58,705,653
Ensembl chr 1:58,693,411...58,705,397
|
|
G |
Has2 |
hyaluronan synthase 2 |
|
IEP |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
IEP ISO |
protein:increased expression:urine: |
RGD |
PMID:23552495 PMID:23019274 PMID:23085062 |
RGD:7244372, RGD:7245495, RGD:7245489 |
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment severity |
IDA IMP |
|
RGD |
PMID:17519789 PMID:22432008 |
RGD:1626334, RGD:9068883 |
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IMP |
|
RGD |
PMID:21291499 |
RGD:10755580 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
|
IEP |
protein:increased expression:kidney (rat) |
RGD |
PMID:23102208 |
RGD:10402775 |
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
IEP |
|
RGD |
PMID:7569112 |
RGD:7242788 |
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hyal1 |
hyaluronidase 1 |
|
IEP |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 8:108,250,654...108,254,526
Ensembl chr 8:108,250,667...108,260,210
|
|
G |
Hyal2 |
hyaluronidase 2 |
|
IEP |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 8:108,241,895...108,246,853
Ensembl chr 8:108,243,133...108,246,850
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
|
RGD |
PMID:28355607 |
RGD:14975115 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
IEP |
mRNA: increased expression: kidney: 3 and 5 days post ischemia |
RGD |
PMID:10990448 |
RGD:7242905 |
NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
treatment |
IMP |
|
RGD |
PMID:19546526 |
RGD:7495779 |
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
treatment |
IDA ISO |
|
RGD |
PMID:24079335 PMID:28664613 |
RGD:7364864, RGD:14975137 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18 |
interleukin 18 |
treatment |
IMP |
|
RGD |
PMID:22089199 |
RGD:8655971 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
|
IDA |
|
RGD |
PMID:20030532 |
RGD:7175501 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
rat model treated with human protein mouse model treated with human protein |
RGD |
PMID:18363573 PMID:9555664 PMID:16849996 |
RGD:6907101, RGD:6909149, RGD:6907359 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Inhbb |
inhibin subunit beta B |
|
IEP |
protein:increased expression:serum (rat) |
RGD |
PMID:27732750 |
RGD:329322881 |
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
|
|
G |
Itgb2 |
integrin subunit beta 2 |
|
ISO IMP |
Associated with renal transplant patients |
RGD |
PMID:20504838 PMID:11007822 |
RGD:6907049, RGD:6907073 |
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Kcnj11 |
potassium inwardly-rectifying channel, subfamily J, member 11 |
|
IEP |
protein:decreased expression:kidney |
RGD |
PMID:21250976 |
RGD:7297045 |
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
|
|
G |
Kl |
Klotho |
treatment |
IEP ISO |
mRNA,protein:decreased expression:renal tubule: |
RGD |
PMID:16204278 PMID:16204278 |
RGD:10403064, RGD:10403064 |
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
|
ISO |
protein:increased expression:kidney (mouse) |
RGD |
PMID:31570196 |
RGD:155888490 |
NCBI chr 8:45,116,771...45,193,320
Ensembl chr 8:45,118,814...45,193,181
|
|
G |
Lcn2 |
lipocalin 2 |
|
IEP ISO |
protein:increased expression:urine: mRNA,protein:increased expression:kidney,urine mRNA,protein:increased expression:kidney: |
RGD |
PMID:23364806 PMID:27800610 PMID:20181666 PMID:23085062 |
RGD:7245469, RGD:126790572, RGD:126779563, RGD:7245489 |
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lep |
leptin |
resistance |
IDA |
|
RGD |
PMID:22969992 |
RGD:6909133 |
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lgals3 |
galectin 3 |
|
IEP |
mRNA:increased expression:kidney |
RGD |
PMID:10980121 |
RGD:9685228 |
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
treatment |
ISO IEP |
|
RGD |
PMID:20075199 PMID:26412257 |
RGD:11561916, RGD:11561958 |
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
treatment |
IMP |
|
RGD |
PMID:23952292 |
RGD:10412647 |
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
|
|
G |
Mc1r |
melanocortin 1 receptor |
|
IEP |
protein:decreased expression:kidney outer medulla |
RGD |
PMID:18790174 |
RGD:5687322 |
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
|
|
G |
Mir146a |
microRNA 146a |
treatment |
IEP |
|
RGD |
PMID:27760486 |
RGD:155882556 |
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir320a |
microRNA 320a |
treatment |
IEP |
|
RGD |
PMID:31089916 PMID:27760486 |
RGD:155882543, RGD:155882556 |
NCBI chr15:45,516,392...45,516,473
Ensembl chr15:45,516,392...45,516,473
|
|
G |
Mir381 |
microRNA 381 |
|
IEP |
RNA:decreased expression:kidney |
RGD |
PMID:29073721 |
RGD:13825150 |
NCBI chr 6:128,740,976...128,741,036
|
|
G |
Mir423 |
microRNA 423 |
treatment |
IMP |
|
RGD |
PMID:29137244 |
RGD:158014894 |
NCBI chr10:61,914,142...61,914,220
Ensembl chr10:61,914,133...61,914,226
|
|
G |
Mir494 |
microRNA 494 |
ameliorates |
ISO |
|
RGD |
PMID:23160513 |
RGD:155883172 |
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
|
|
G |
Mpo |
myeloperoxidase |
|
IEP ISO |
protein:increased activity:kidney |
RGD |
PMID:22950848 PMID:18055546 |
RGD:6909167, RGD:7174699 |
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Muc1 |
mucin 1, cell surface associated |
treatment |
IDA |
|
RGD |
PMID:22019164 |
RGD:7245959 |
NCBI chr 2:174,635,559...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
IEP |
mRNA:increased expression:kidney (rat) |
RGD |
PMID:17220792 |
RGD:7207777 |
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
|
IEP ISO |
|
RGD |
PMID:24096033 PMID:22160772 |
RGD:13801197, RGD:13801199 |
NCBI chr 1:243,408,659...243,413,701
Ensembl chr 1:243,408,619...243,413,817
|
|
G |
Nes |
nestin |
|
IEP |
|
RGD |
PMID:24503548 |
RGD:11570523 |
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
IEP |
|
RGD |
PMID:31089916 |
RGD:155882543 |
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IEP |
|
RGD |
PMID:29291552 |
RGD:13504682 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
|
RGD |
PMID:20471588 |
RGD:7247717 |
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IEP |
|
RGD |
PMID:21545725 |
RGD:11035217 |
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
severity |
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:22343121 PMID:22343121 |
RGD:14700869, RGD:14700869 |
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
IEP |
|
RGD |
PMID:12531391 |
RGD:2317150 |
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pax2 |
paired box 2 |
|
IEP |
mRNA, protein:increased expression:kidney |
RGD |
PMID:12444203 |
RGD:727468 |
NCBI chr 1:243,616,509...243,697,454
Ensembl chr 1:243,616,606...243,695,321
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
IEP |
mRNA,protein:increased expression:tubule, S3 segment: |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
IEP |
mRNA:increased expression:kidney |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
IMP IEP |
mRNA:increased expression:kidney |
RGD |
PMID:12819032 PMID:10550325 |
RGD:1580850, RGD:8554477 |
NCBI chr18:54,500,002...54,538,843
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pkd2 |
polycystin 2, transient receptor potential cation channel |
|
IEP |
protein:increased expression:kidney (rat) |
RGD |
PMID:12454224 |
RGD:1580868 |
NCBI chr14:5,237,135...5,280,455
Ensembl chr14:5,237,135...5,280,825
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
treatment |
IDA |
|
RGD |
PMID:24918615 |
RGD:10059636 |
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Rnls |
renalase, FAD-dependent amine oxidase |
|
ISO |
mRNA,protein:decreased expression:kidney,plasma: |
RGD |
PMID:23393318 PMID:23393318 |
RGD:7327166, RGD:7327166 |
NCBI chr 1:231,037,481...231,309,855
Ensembl chr 1:231,037,486...231,309,823
|
|
G |
Serpina1 |
serpin family A member 1 |
treatment |
ISO |
|
RGD |
PMID:28235038 |
RGD:14695051 |
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Serpinc1 |
serpin family C member 1 |
severity |
IMP |
|
RGD |
PMID:26108065 PMID:26108065 |
RGD:11354006, RGD:11354006 |
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Serpinc1em2Mcwi |
serpin family C member 1; ZFN induced mutant 2, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:26108065 |
RGD:11354006 |
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:24744439 |
RGD:12859042 |
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
IEP |
|
RGD |
PMID:22324445 |
RGD:9495930 |
NCBI chr20:25,307,143...25,329,260
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Six2 |
SIX homeobox 2 |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 6:8,974,859...8,981,345
Ensembl chr 6:8,967,157...8,981,193
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
|
IEP |
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
IEP |
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
IEP |
protein:decreased expression:renal proximal tubule, brush border membrane (rat) |
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chr17:9,218,876...9,233,852
Ensembl chr17:9,218,876...9,233,852
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
|
IEP |
|
RGD |
PMID:12819032 |
RGD:1580850 |
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
severity |
ISO |
|
RGD |
PMID:12709397 |
RGD:7244143 |
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
|
|
G |
Suz12 |
SUZ12 polycomb repressive complex 2 subunit |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr10:64,967,035...65,012,916
Ensembl chr10:64,966,967...65,012,738
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:11796005 |
RGD:11062062 |
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
|
|
G |
Tlr2 |
toll-like receptor 2 |
treatment severity |
IDA ISO |
|
RGD |
PMID:23239000 PMID:11801667 PMID:20130923 PMID:22750071 PMID:23023072 |
RGD:7207892, RGD:7241087, RGD:7240552, RGD:7207896, RGD:7207894 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment |
IDA ISO |
|
RGD |
PMID:23239000 PMID:11801667 PMID:20130923 |
RGD:7207892, RGD:7241087, RGD:7240552 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:19925291 |
RGD:2315112 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:22728466 |
RGD:7245543 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
IEP |
protein:increased expression:kidney |
RGD |
PMID:20164827 |
RGD:7240507 |
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vwf |
von Willebrand factor |
|
IEP |
protein:increased expression:serum: |
RGD |
PMID:12684225 |
RGD:11080744 |
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
|
|
G |
Wt1 |
WT1 transcription factor |
|
ISO |
mRNA:altered expression:kidney (mouse) |
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IMP |
associated with Diabetes Mellitus, Type 2 |
RGD |
PMID:22995295 PMID:20616412 |
RGD:7247637, RGD:7247695 |
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
IDA |
|
RGD |
PMID:23762489 |
RGD:8695935 |
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adm |
adrenomedullin |
treatment |
IEP ISO |
mRNA,protein:increased expression:liver,plasma: |
RGD |
PMID:19212187 PMID:19212187 |
RGD:7364958, RGD:7364958 |
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:21431875 |
RGD:10402078 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
treatment |
ISO IEP |
protein:altered expression:liver (mouse) protein:altered expression:liver (rat) |
RGD |
PMID:30671488 PMID:29589772 |
RGD:15036807, RGD:14975297 |
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Bad |
BCL2-associated agonist of cell death |
treatment |
IEP |
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22647552 PMID:22847887 |
RGD:10053673, RGD:10053710 |
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22647552 PMID:21092002 PMID:22847887 |
RGD:10053673, RGD:5134995, RGD:10053710 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IDA IEP |
associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22847887 PMID:21092002 |
RGD:10053710, RGD:5134995 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
treatment |
IEP |
associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22847887 |
RGD:10053710 |
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
C3 |
complement C3 |
treatment |
IEP |
|
RGD |
PMID:19854450 |
RGD:11040888 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Casp12 |
caspase 12 |
treatment |
IEP |
|
RGD |
PMID:29428101 |
RGD:13782166 |
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp8 |
caspase 8 |
treatment |
IEP ISO |
|
RGD |
PMID:23423194 PMID:15300206 |
RGD:8661760, RGD:14695087 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
treatment |
IEP |
|
RGD |
PMID:23364428 |
RGD:13782358 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment severity |
IEP ISO |
mRNA, protein:increased expression:liver, serum (rat) |
RGD |
PMID:9500701 PMID:10630515 PMID:27229110 |
RGD:8549627, RGD:14995929, RGD:14995460 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
treatment severity |
ISO |
|
RGD |
PMID:28623253 PMID:28623253 |
RGD:14995305, RGD:14995305 |
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
severity |
ISO |
|
RGD |
PMID:27229110 |
RGD:14995460 |
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Cd14 |
CD14 molecule |
|
IDA |
|
RGD |
PMID:22564590 |
RGD:7183676 |
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd40 |
CD40 molecule |
treatment |
IMP |
|
RGD |
PMID:14741776 |
RGD:8547795 |
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cfh |
complement factor H |
treatment |
IEP ISO |
mRNA,protein:decreased expression:liver,plasma: |
RGD |
PMID:19212187 PMID:19212187 |
RGD:7364958, RGD:7364958 |
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Cs |
citrate synthase |
|
IDA |
|
RGD |
PMID:25416448 |
RGD:13504849 |
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
treatment |
IDA |
|
RGD |
PMID:21092002 |
RGD:5134995 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:18041715 |
RGD:27095942 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
IEP |
mRNA:decreased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Elane |
elastase, neutrophil expressed |
|
IMP |
|
RGD |
PMID:10588515 |
RGD:10450560 |
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Epor |
erythropoietin receptor |
|
IEP |
protein:increased phosphorylation:liver: |
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
|
|
G |
F3 |
coagulation factor III, tissue factor |
treatment |
IMP |
|
RGD |
PMID:11750579 |
RGD:11341708 |
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
IEP |
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
IMP IEP |
protein:increased expression:liver |
RGD |
PMID:17235585 PMID:18561025 PMID:16222447 |
RGD:2290283, RGD:14700680, RGD:1600351 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
treatment |
IMP |
|
RGD |
PMID:18561025 |
RGD:14700680 |
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fga |
fibrinogen alpha chain |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:23503399 |
RGD:9685021 |
NCBI chr 2:168,365,364...168,381,533
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fn1 |
fibronectin 1 |
|
IDA |
|
RGD |
PMID:12651615 |
RGD:7205470 |
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
IDA |
associated with nonalcoholic fatty liver disease |
RGD |
PMID:28807209 |
RGD:13792730 |
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
IEP |
mRNA:decreased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
H2ax |
H2A.X variant histone |
treatment |
IEP |
|
RGD |
PMID:23792534 |
RGD:8693718 |
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
IMP IEP |
protein:increased oxidation:liver mRNA, protein:increased expression, altered localization:serum, hepatocyte, cytoplasm |
RGD |
PMID:24578610 PMID:22514737 PMID:21431875 |
RGD:10402068, RGD:10402175, RGD:10402078 |
NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IEP |
|
RGD |
PMID:20446775 |
RGD:10755725 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hp |
haptoglobin |
treatment |
IEP |
|
RGD |
PMID:17187421 PMID:21699906 |
RGD:1626366, RGD:11041815 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
IMP IEP |
associated with Intestinal Reperfusion Injury;protein:increased expression:liver |
RGD |
PMID:7884306 PMID:8780571 |
RGD:11520784, RGD:14402044 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
|
RGD |
PMID:28938192 |
RGD:14985248 |
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
treatment |
IDA |
|
RGD |
PMID:22381173 |
RGD:12791280 |
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
|
|
G |
Il10 |
interleukin 10 |
treatment |
IDA |
|
RGD |
PMID:21911118 |
RGD:7364839 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18 |
interleukin 18 |
treatment |
IEP ISO |
|
RGD |
PMID:25919765 PMID:14999688 |
RGD:14696667, RGD:14696668 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
IEP |
mRNA,protein:increased expression:liver |
RGD |
PMID:25919765 |
RGD:14696667 |
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
|
|
G |
Il1a |
interleukin 1 alpha |
treatment |
IEP IDA |
mRNA:increased expression:lung protein:increased expression:serum |
RGD |
PMID:19595018 PMID:9840148 PMID:19283466 |
RGD:2314952, RGD:11059517, RGD:6907377 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
IDA ISO |
associated with Cholestasis |
RGD |
PMID:21468628 PMID:32155285 |
RGD:7175318, RGD:155260323 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO IMP |
rat model treated with human protein |
RGD |
PMID:9000676 PMID:12451245 |
RGD:6909138, RGD:8551710 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il6 |
interleukin 6 |
treatment |
IDA ISO |
|
RGD |
PMID:24752458 PMID:32155285 |
RGD:11062134, RGD:155260323 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
IDA |
|
RGD |
PMID:22288937 |
RGD:10403073 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:12134092 |
RGD:9685192 |
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
ameliorates exacerbates |
ISO |
protein:increased phosphorylation:liver (mouse) |
RGD |
PMID:30076625 PMID:30622220 |
RGD:155804280, RGD:155882441 |
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
IEP |
protein:increased activity:liver: |
RGD |
PMID:11679968 |
RGD:10412680 |
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mfn2 |
mitofusin 2 |
treatment |
IEP |
mRNA, protein:decreased expression:liver (rat) |
RGD |
PMID:27363631 PMID:24898700 |
RGD:12910833, RGD:13204829 |
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mir145 |
microRNA 145 |
|
IEP |
mRNA:decreased expression:small intestine (rat) |
RGD |
PMID:23166305 |
RGD:155230822 |
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
|
RGD |
PMID:28640790 |
RGD:21079442 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir21 |
microRNA 21 |
|
IEP |
RNA:increased expression:liver |
RGD |
PMID:29187695 |
RGD:41410824 |
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir210 |
microRNA 210 |
treatment |
ISO |
|
RGD |
PMID:32155285 |
RGD:155260323 |
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
|
|
G |
Mir223 |
microRNA 223 |
|
ISO |
RNA:increased expression:liver RNA:increased expression:serum,liver |
RGD |
PMID:19104939 PMID:28646120 |
RGD:13831297, RGD:21408574 |
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
|
|
G |
Mir34a |
microRNA 34a |
|
IEP |
miRNA:increased expression:liver |
RGD |
PMID:28963950 |
RGD:14695005 |
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
|
|
G |
Mmp15 |
matrix metallopeptidase 15 |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr19:9,663,449...9,684,943
Ensembl chr19:9,663,449...9,684,943
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
IEP |
associated with Fatty Liver;mRNA, protein:decreased expression, decreased activity:liver |
RGD |
PMID:17255325 |
RGD:8547976 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
IEP |
mRNA, protein:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr 2:174,635,559...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Muc3 |
mucin 3 |
|
IEP |
mRNA, protein:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr12:19,527,251...19,536,924
Ensembl chr12:19,527,321...19,538,522
|
|
G |
Muc4 |
mucin 4, cell surface associated |
|
IEP |
mRNA:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr11:68,008,245...68,053,229
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
|
ISO |
mRNA,protein:increased expression:liver: |
RGD |
PMID:36092961 |
RGD:268357360 |
NCBI chr18:74,046,421...74,156,041
Ensembl chr18:74,046,904...74,156,028
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
IEP |
|
RGD |
PMID:22288937 PMID:31952110 |
RGD:10403073, RGD:21201304 |
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IEP |
|
RGD |
PMID:28966130 |
RGD:13450941 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:12605111 PMID:18507760 |
RGD:11100021, RGD:11100046 |
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
|
|
G |
Serpinc1 |
serpin family C member 1 |
treatment |
IEP ISO |
|
RGD |
PMID:24726586 PMID:8589354 |
RGD:10450597, RGD:11038771 |
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Serpine1 |
serpin family E member 1 |
|
IEP |
protein:increased activity:plasma (rat) |
RGD |
PMID:12353078 |
RGD:8547901 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:16367929 |
RGD:1580273 |
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
IEP |
|
RGD |
PMID:24557422 |
RGD:9497542 |
NCBI chr20:25,307,143...25,329,260
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
IEP |
|
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
|
|
G |
Sod1 |
superoxide dismutase 1 |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:16555330 PMID:11779401 |
RGD:8655889, RGD:1581095 |
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod3 |
superoxide dismutase 3 |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:11779401 |
RGD:1581095 |
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Tert |
telomerase reverse transcriptase |
treatment |
ISO |
|
RGD |
PMID:19545665 |
RGD:11038676 |
NCBI chr 1:29,637,213...29,659,509
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:9921794 |
RGD:11062061 |
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
|
|
G |
Tlr2 |
toll-like receptor 2 |
treatment |
ISO IEP |
|
RGD |
PMID:16038046 PMID:25769561 |
RGD:15090805, RGD:15090809 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment severity |
IEP ISO |
mRNA:increased expression:liver protein:increased expression:membrane raft: |
RGD |
PMID:21431875 PMID:21693218 PMID:22797797 PMID:23395256 PMID:27064547 |
RGD:10402078, RGD:5685379, RGD:14697702, RGD:14697699, RGD:14697698 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
IEP ISO IMP |
protein:increased expression:serum (rat) |
RGD |
PMID:24726586 PMID:32155285 PMID:11592783 PMID:19357028 PMID:11129814 PMID:21125813 PMID:10454827 PMID:15457564 PMID:17164725 More...
|
RGD:10450597, RGD:155260323, RGD:2325259, RGD:15039406, RGD:14995473, RGD:14995447, RGD:14985258, RGD:14985257, RGD:14696803 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
IEP |
protein:increased localization:mitochondrion |
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tradd |
TNFRSF1A-associated via death domain |
treatment |
IEP |
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr19:33,136,148...33,142,714
Ensembl chr19:33,136,138...33,142,638
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:22195248 |
RGD:7175309 |
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
IEP |
|
RGD |
PMID:26451003 |
RGD:15036791 |
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:24768926 |
RGD:13209011 |
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment ameliorates |
IEP ISO |
|
RGD |
PMID:23953793 PMID:34238924 |
RGD:10054119, RGD:153350155 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Crebbp |
CREB binding protein |
ameliorates |
ISO |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Egr1 |
early growth response 1 |
treatment |
IMP IEP |
|
RGD |
PMID:22878149 PMID:23232597 |
RGD:10395282, RGD:10395299 |
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Elane |
elastase, neutrophil expressed |
treatment |
IMP |
|
RGD |
PMID:17888675 |
RGD:10450582 |
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
mRNA:increased expression:lung (rat) |
RGD |
PMID:35600952 |
RGD:155663563 |
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:21227458 |
RGD:10755577 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
IEP |
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il1b |
interleukin 1 beta |
ameliorates |
IDA ISO IEP |
protein:increased expression:lung (rat) |
RGD |
PMID:23142117 PMID:34238924 PMID:23122581 |
RGD:7183185, RGD:153350155, RGD:7204125 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
treatment |
IDA |
|
RGD |
PMID:24365768 |
RGD:10402797 |
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
ameliorates |
ISO |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
ameliorates |
ISO |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
protein:increased activity:lung |
RGD |
PMID:18694576 |
RGD:5129703 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
treatment |
IEP |
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
IMP ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:20815765 PMID:25382268 |
RGD:4892012, RGD:11533932 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IEP |
|
RGD |
PMID:21781312 |
RGD:6771212 |
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
IDA IEP |
protein:increased expression:alveolar macrophage (rat) |
RGD |
PMID:21781312 PMID:16449942 |
RGD:6771212, RGD:11541083 |
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:19782612 |
RGD:11100035 |
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO IDA |
protein:increased expression:plasma (human) |
RGD |
PMID:17846288 PMID:11606484 |
RGD:8547720, RGD:11080966 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment |
IEP |
|
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
ameliorates |
IMP ISO |
|
RGD |
PMID:17294835 PMID:34238924 |
RGD:4143397, RGD:153350155 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Zfp36 |
zinc finger protein 36 |
exacerbates |
ISO |
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
|
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
|
ISO |
|
RGD |
PMID:18316485 |
RGD:2301903 |
NCBI chr 1:96,598,663...96,679,495
Ensembl chr 1:96,598,647...96,679,510
|
|
G |
Ada |
adenosine deaminase |
|
IDA |
protein:increased expression |
RGD |
PMID:16641873 |
RGD:1624305 |
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16155579 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10900253 PMID:17201736 |
RGD:5129149 |
NCBI chr 1:255,772,217...255,773,617
Ensembl chr 1:255,771,597...255,807,259
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
IDA |
|
RGD |
PMID:16269402 |
RGD:1598746 |
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
IEP |
protein:increased expression:heart (rat) |
RGD |
PMID:16505177 |
RGD:1625342 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Agl |
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
|
IMP |
|
RGD |
PMID:9281456 |
RGD:1598779 |
NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:2535056 PMID:19166939 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
IEP |
protein:increased expression:myocardium |
RGD |
PMID:21078800 |
RGD:5129194 |
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
|
IEP ISO |
protein:decreased expression:mitochondrion: |
RGD |
PMID:23685150 PMID:23685150 |
RGD:10053560, RGD:10053560 |
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
IDA |
protein:increased phosphorylation:heart left ventricle |
RGD |
PMID:20217242 |
RGD:5509104 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
|
IDA |
|
RGD |
PMID:16418318 |
RGD:2313347 |
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9572063 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
IDA |
|
RGD |
PMID:23468836 |
RGD:7241598 |
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
IMP |
|
RGD |
PMID:20011686 |
RGD:2317527 |
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Angpt2 |
angiopoietin 2 |
|
IEP |
mRNA, protein:increased expression:myocardium (rat) |
RGD |
PMID:12737621 |
RGD:1601505 |
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
|
|
G |
Ank1 |
ankyrin 1 |
|
IDA |
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chr16:68,876,294...69,054,812
Ensembl chr16:68,877,504...69,054,759
|
|
G |
Ank2 |
ankyrin 2 |
|
IDA |
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
|
IEP |
protein:decreased expression:myocardium |
RGD |
PMID:19299913 |
RGD:5133278 |
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Anxa1 |
annexin A1 |
treatment |
IEP ISO |
protein:increased expression:heart, leukocyte |
RGD |
PMID:11641252 PMID:22924634 PMID:22924634 |
RGD:2306910, RGD:7421655, RGD:7421655 |
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
IEP |
protein:altered localization:cytoplasm |
RGD |
PMID:17602955 |
RGD:2315672 |
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Arrb2 |
arrestin, beta 2 |
|
IEP |
|
RGD |
PMID:29016703 |
RGD:13506827 |
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Atf3 |
activating transcription factor 3 |
|
IEP |
|
RGD |
PMID:11485922 |
RGD:7327201 |
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29702141 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
|
IMP |
|
RGD |
PMID:17630344 |
RGD:13782075 |
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10734148 PMID:28637456 |
RGD:13782080 |
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
IEP |
protein:decreased expression:myocardium (rat) |
RGD |
PMID:26109848 PMID:25305180 |
RGD:13792666, RGD:13792676 |
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
|
|
G |
Bad |
BCL2-associated agonist of cell death |
treatment |
IEP IDA |
protein:increased expression, decreased serine phosphorylation:heart |
RGD |
PMID:15339931 PMID:23364609 |
RGD:2292700, RGD:10053674 |
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20026869 PMID:21223820 PMID:25547710 PMID:31583047 |
RGD:10054103, RGD:13782178, RGD:155230831 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP IDA |
|
RGD |
PMID:16289365 PMID:23364609 PMID:20821058 PMID:31583047 |
RGD:1599484, RGD:10053674, RGD:11561911, RGD:155230831 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
treatment |
IDA |
|
RGD |
PMID:12668130 |
RGD:11035287 |
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Becn1 |
beclin 1 |
treatment |
IDA ISO |
|
RGD |
PMID:20821058 PMID:20812860 |
RGD:11561911, RGD:11561944 |
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
IDA IEP |
protein:increased cleavage:heart: |
RGD |
PMID:19940077 PMID:11934844 |
RGD:2317561, RGD:13782263 |
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Blk |
BLK proto-oncogene, Src family tyrosine kinase |
|
IEP |
mRNA:increased expression:left ventricle (rat) |
RGD |
PMID:17562528 |
RGD:1642307 |
NCBI chr15:37,626,746...37,665,053
Ensembl chr15:37,627,039...37,665,031
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
treatment |
IMP IEP |
protein:decreased expression:myocardium (human) |
RGD |
PMID:16645637 PMID:28661226 |
RGD:11561983, RGD:155260328 |
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Brd4 |
bromodomain containing 4 |
|
ISO |
mRNA,protein:increased expression:heart |
RGD |
PMID:33982231 |
RGD:155883171 |
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
IEP |
mRNA:increased expression:heart |
RGD |
PMID:12909328 |
RGD:2289075 |
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
C3 |
complement C3 |
|
IEP |
protein:increased expression:myocardium |
RGD |
PMID:11560858 |
RGD:1582136 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C5 |
complement C5 |
treatment |
IDA IMP |
|
RGD |
PMID:9631876 PMID:23067403 |
RGD:1600666, RGD:7411626 |
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Casp1 |
caspase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14998631 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
treatment |
IEP ISO |
protein:increased activity:myocardium CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14998631 PMID:19406177 PMID:25547710 |
RGD:2311458, RGD:13782178 |
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
treatment ameliorates |
IMP ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14998631 PMID:18470603 PMID:29538428 PMID:30259997 |
RGD:2293314, RGD:13782276, RGD:329337366 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14998631 PMID:29538428 |
RGD:13782276 |
NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte |
CTD RGD |
PMID:14998631 PMID:11934844 |
RGD:13782263 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
treatment ameliorates |
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte,endothelial cell |
CTD RGD |
PMID:14998631 PMID:11934844 PMID:29538428 PMID:30259997 |
RGD:13782263, RGD:13782276, RGD:329337366 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Casr |
calcium-sensing receptor |
|
IEP |
protein:increased expression:ventricular myocardium (rat) |
RGD |
PMID:21766206 |
RGD:7205698 |
NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811
|
|
G |
Cast |
calpastatin |
|
IEP |
|
RGD |
PMID:12482022 |
RGD:5683872 |
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Cat |
catalase |
|
IEP ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:21600015 PMID:11510883 |
RGD:1581149 |
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbl |
Cbl proto-oncogene |
severity |
ISO |
|
RGD |
PMID:24583314 |
RGD:11251947 |
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP ISO |
mRNA:increased expression:heart (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12087064 PMID:10908159 |
RGD:8549625 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
protein:decreased expression:monocyte: |
RGD |
PMID:15786508 |
RGD:4892017 |
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
treatment |
ISO IEP |
protein:decreased expression:blood, monocyte (human) |
RGD |
PMID:15786508 PMID:23456481 |
RGD:4892017, RGD:8552227 |
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:18466417 |
RGD:11341714 |
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
IMP |
|
RGD |
PMID:18771032 |
RGD:2316217 |
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
|
IMP |
|
RGD |
PMID:17950273 |
RGD:2316224 |
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
|
|
G |
Cobll1 |
cordon-bleu WH2 repeat protein-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34355838 |
|
NCBI chr 3:49,753,260...49,915,168
Ensembl chr 3:49,753,262...49,915,194
|
|
G |
Crebbp |
CREB binding protein |
treatment |
IEP |
|
RGD |
PMID:24338162 |
RGD:153352322 |
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crp |
C-reactive protein |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:21122204 |
RGD:5128547 |
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
protein:decreased expression:blood, monocyte |
RGD |
PMID:15786508 |
RGD:4892017 |
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IMP |
|
RGD |
PMID:11342480 |
RGD:5135269 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IMP |
|
RGD |
PMID:11342480 |
RGD:5135269 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl6 |
C- | |